NOI - Olink Explore HT Proteomic Analysis for Sickle Cell Disease Study
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), intends to award a non-competitive, firm-fixed-price purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. This requirement supports a longitudinal study investigating transthyretin (TTR) variants in sickle cell disease severity. While the intent is to award to PSOMagen, Inc., interested parties may submit capability statements. Responses are due May 13, 2026, at 9:00 AM EDT.
Scope of Work
This opportunity requires proteomic profiling services using the Olink Explore HT platform with Next Generation Sequencing (NGS)-based readout. Key deliverables include:
- Quantification of over 5,400 proteins per sample.
- Standardized sample processing and assay execution using Olink Proximity Extension Assay (PEA) technology.
- Comprehensive quality control.
- Delivery of complete, analysis-ready, normalized datasets compatible with previously generated study data.
- Ensuring consistency in assay performance, data processing, and output for an ongoing longitudinal study.
Contract Details
- Contract Type: Firm-fixed-price purchase order.
- Period of Performance: Supports an ongoing longitudinal study (not explicitly stated).
- Set-Aside: None (non-competitive, identifying PSOMagen, Inc. as the only capable vendor).
- NAICS Code: 541380 – Testing Laboratories and Services (Small Business Size Standard: $19M).
Submission & Eligibility
This is a Notice of Intent for a non-competitive award. Interested parties must submit capability statements demonstrating their ability to meet the Government’s requirement. Required information includes:
- Unit price, list price, shipping/handling costs, delivery days after award, delivery terms, prompt payment discount terms, F.O.B. Point.
- Product/catalog number, product description, and documentation proving adherence to characteristics.
- Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification.
- Active registration in SAM.gov is mandatory.
- Submission Deadline: May 13, 2026, at 9:00 AM EDT.
- Submission Method: Electronically to nicholas.capobianco@nih.gov.
- Evaluation: Governed by FAR clause 52.212-2, Evaluation – Commercial Items.
Additional Information
This is a combined synopsis/solicitation issued under FAR Part 12.6 and 41 U.S.C. 1901, and FAR 6.302-3(a)(2)(ii). The acquisition is not expected to exceed the simplified acquisition threshold.